Latest Advances

  • Condition: T Cell Prolymphocytic Leukemia (T-PLL)
  • Journal: Current hematologic malignancy reports
  • Treatment Used: Alemtuzumab Infusion Followed by Allogeneic Hematopoietic Stem Cell Transplantation (all-HSCT)
  • Number of Patients: 0
  • Published —
This study summarized current treatments for T cell prolymphocytic leukemia (T-PLL).
  • Condition: T-prolymphocytic leukemia
  • Journal: Annals of hematology
  • Treatment Used: Allogeneic hematopoietic cell transplantation
  • Number of Patients: 20
  • Published —
This study aimed to analyze the outcomes of allogeneic hematopoietic cell transplantation (HCT) among patients with T-prolymphocytic leukemia (T-PLL) to identify the potential clinical efficacy of allogeneic HCT.
  • Condition: B-cell chronic lymphoproliferative disorders (B-CLPD) with TP53 abnormalities
  • Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
  • Treatment Used: high-dose methylprednisolone with Rituximab and fresh frozen plasma (HDMP+RTX+FFP)
  • Number of Patients: 6
  • Published —
This study assessed whether high-dose methylprednisolone with rituximab and fresh frozen plasma (HDMP+RTX+FFP) for up to six cycles in improving outcomes for patients with B-cell chronic lymphoproliferative disorders (B-CLPD) with TP53 abnormalities.
  • Condition: T-Prolymphocytic Leukemia (T-PLL)
  • Journal: Bone marrow transplantation
  • Treatment Used: Allogeneic Hematopoietic Stem Cell Transplant (Allo-SCT)
  • Number of Patients: 37
  • Published —
This study tested the safety and efficacy of using allo-SCT to treat patients with T-PLL.
  • Condition: T-Cell Prolymphocytic Leukemia (T-PLL)
  • Journal: Leukemia research
  • Treatment Used: Allogeneic Hematopoietic Cell Transplantation (allo-HCT)
  • Number of Patients: 11
  • Published —
This study evaluated clinical outcomes of patients who underwent allogeneic hematopoietic cell transplantation (allo-HCT) for T-cell prolymphocytic leukemia (T-PLL).
Showing 1-5 of 5